Catalyst Wire Dossier Catalyst Wire Dossier

GS-9973

· Gilead Sciences
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GS-9973, covering 2014-02-07 to 2014-02-07. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of Novel GS-9973 Tablet Formulations to Evaluate the Effect of Acid Reducing Agents, Relative Bioavailability, and Food Effect on GS-9973 Pharmacokinetics [Phase 1]

See pricing